Bonnevie Pharma Private Limited

Bonnevie Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH2008PTC184631 Incorporated 14 July 2008 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹36.62 Lakh
▼ 84% YoY
Net profit · FY 2025
₹28.5 Lakh
Net margin 77.8%
EBITDA · FY 2025
₹29.12 Lakh
EBITDA margin 79.5%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹24 Lakh
Secured borrowings
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings

About Bonnevie Pharma Private Limited

Data last updated:

Bonnevie Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 July 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2008PTC184631. Its GSTIN is 27AADCB5162A1Z5 (Maharashtra).

The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veer Vinodkumar Dadhia and Neha Himesh Dadhia.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/302 Jamana Darshan Chs Dr N. R. Korade Marg S. V. Road Borivali(West), Mumbai, Maharashtra, India – 400092.

As per the financials filed for FY 2025, the company reported a revenue of ₹36.62 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net profit of ₹28.5 Lakh (net margin 77.8%) and EBITDA of ₹29.12 Lakh (EBITDA margin 79.5%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 39% over five years.

As per MCA filings, the company has open charges of ₹24 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239MH2008PTC184631
Registration Number 184631
Incorporation Date 14 July 2008
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Bonnevie Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B/302 Jamana Darshan Chs Dr N. R. Korade Marg S. V. Road Borivali(West), Mumbai, Maharashtra, India – 400092
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Bonnevie Pharma Private Limited, buy the company report.

Comprehensive company report
Bonnevie Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bonnevie Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Bonnevie Pharma Private Limited, buy the company report.

Financials of Bonnevie Pharma Private Limited

FY 2025 filings available

Bonnevie Pharma Private Limited reported revenue of ₹36.62 Lakh (down 84% YoY) for FY 2025.

Revenue · FY 2025
₹36.62 Lakh ▼ 84%
Net profit · FY 2025
₹28.5 Lakh margin 77.8%
EBITDA · FY 2025
₹29.12 Lakh margin 79.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 84%
3 years · compounded
▼ 37%
5 years · compounded
▼ 39%
EBITDA CAGR growth
1 year
▲ 203%
3 years · compounded
▲ 71%
5 years · compounded
▲ 16%

Revenue has declined at a compounded annual rate (CAGR) of 39% over five years, including a 84% fall in the latest year. EBITDA rose 203% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹29.12 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹28.5 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin79.5%
Net Profit Margin77.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bonnevie Pharma Private Limited, buy the company report.

Board of directors of Bonnevie Pharma Private Limited

Bonnevie Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Veer Vinodkumar DadhiaDirector14 Jul 200818 Years 3 MonthsCurrent
Neha Himesh DadhiaDirector19 Nov 20223 Years 11 MonthsCurrent

Auditor

Bonnevie Pharma Private Limited is audited by Parekh & Co. for the financial year 2016.

Auditor firmFinancial yearFirm registration number
Parekh & Co.FY 2016

Shareholding

The shareholding of Bonnevie Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bonnevie Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹24 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.24 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Sep 201510598236Others₹24 LakhOpen

To see the full charge records of Bonnevie Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bonnevie Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Bonnevie Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AADCB5162A1Z5MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Bonnevie Pharma Private Limited, buy the company report.

Recent activity

Bonnevie Pharma Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Himesh Ramesh Dadhia ceased to be Director on 21 Nov 2022.

AGM
Bonnevie Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bonnevie Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Himesh Ramesh Dadhia ceased to be Director.
Appointed
Neha Himesh Dadhia was appointed as Director.
Charges
A charge with Others of Rs. 24.00 Lakh registered on 28 Sep 2015 with Charge ID 10598236 was modified on 20 May 2019.
Charges
A charge with Others amounted to Rs. 24.00 Lakh with Charge ID 10598236 was registered on 28 Sep 2015.
Ceased
Santosh Deshpande ceased to be Director.
Appointed
Veer Vinodkumar Dadhia was appointed as Director.
Incorporation
14 Jul 2008
Bonnevie Pharma Private Limited was registered on 14 Jul 2008 with Roc Mumbai I & aged 18 years 4 months as per MCA records.

Frequently asked questions

Bonnevie Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 July 2008 (18+ years old) and is registered under CIN U24239MH2008PTC184631.

Bonnevie Pharma has 2 current directors:

The latest financial statements of Bonnevie Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Bonnevie Pharma is 27AADCB5162A1Z5, registered in Maharashtra.

The CIN (Corporate Identification Number) of Bonnevie Pharma is U24239MH2008PTC184631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bonnevie Pharma was incorporated on 14 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.

Himesh Ramesh Dadhia ceased to be Director on 21 Nov 2022. Neha Himesh Dadhia was appointed as Director on 19 Nov 2022. Santosh Deshpande ceased to be Director on 30 Oct 2009. Bonnevie Pharma has 4 board changes on record in total.

The registered office of Bonnevie Pharma is at B302 Jamana Darshan Chs Dr N. R. Korade Marg S. V. Road BorivaliWest, Mumbai, Maharashtra, India – 400092.

Bonnevie Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Bonnevie Pharma has open charges of ₹24 Lakh and no satisfied charges on record as per latest MCA filings.